Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2000
11/02/2000EP1047679A1 Herbicidal n-alkenyl heteroarylyloxyacetamides
11/02/2000EP1047425A1 Integrin receptor antagonists
11/02/2000DE19919120A1 Neue Amidopyrylium-Fluoreszenz-Farbstoffe New amidopyrylium fluorescent dyes
11/02/2000DE19919119A1 Neue Carbopyronin-Fluoreszenz-Farbstoffe New carbopyronine fluorescent dyes
11/02/2000CA2369663A1 4-fluoroalkyl-3-halophenyl nortropanes
11/02/2000CA2369109A1 Thrombin inhibitors
11/02/2000CA2367682A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/02/2000CA2367681A1 Azaindole derivatives for the treatment of depression
11/01/2000CN1272110A Tricyclic vasopressin agonists
11/01/2000CN1058014C New heterocyclic spiro compounds, process for preparation thereof, and pharmaceutical compositions containing them
11/01/2000CN1058013C Process for preparation of novel mercaptoacetylamide derivatives
11/01/2000CN1058010C Novel quinoline carboxylic acid derivatives having 7-(4-aminomethyl-3-oxime) pyrrolidine substituent and process for preparing thereof
10/2000
10/31/2000US6140504 Substituted intermediate compounds for the preparation of n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
10/31/2000US6140352 Carbazolyl-substituted ethanolamines as selective β-3 agonists
10/31/2000US6140345 For treating psychoses and pain
10/31/2000US6140333 For treatment and/or prophylaxis of diseases include such respiratory diseases as chronic obstructive pulmonary diseases, chronic bronchitis, asthma, chronic respiratory obstruction, pulmonary fibrosis, pulmonary emphysema
10/31/2000US6140332 Pyrrolopyrimidines and processes for the preparation thereof
10/31/2000US6140330 Thiazole derivative
10/31/2000US6140329 For treating a male animal for erectile dysfunction
10/31/2000US6140328 Heterocyclic cytotoxic agents
10/31/2000US6140322 For therapy or prophylaxis of hypoxia, such as in cases of cardiac arrest, stroke and neonatal hypoxia, neurodegenerative conditions including nerve degeneration and/or nerve necrosis in disorders such as ischaemia, epilepsy, hypoglycemia
10/26/2000WO2000063211A1 Haloalkoxy imidazonaphthyridines
10/26/2000WO2000063210A1 Morphinoid compounds
10/26/2000WO2000063209A1 New compounds, their preparation and use
10/26/2000WO2000063208A1 Substituted imidazoles, their preparation and use
10/26/2000WO2000063185A1 Novel synthesis of piperazine ring
10/26/2000WO2000063140A1 Template directed solid-state organic synthesis
10/26/2000WO2000062782A1 Novel synthesis and crystallization of piperazine ring-containing compounds
10/26/2000WO2000062778A1 Cyclic protein tyrosine kinase inhibitors
10/26/2000WO2000039082A3 1,2-annelated quinoline derivatives
10/26/2000WO2000035886A3 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/26/2000WO2000034286A3 Process for the preparation of pyrimidinone derivatives
10/26/2000WO2000026197A9 Novel inhibitors of impdh enzyme
10/26/2000DE19918725A1 New heterocyclic-substituted N-cyano-sulfonanilide compounds, useful as total or selective pre- or post-emergence herbicides, showing desiccant, defoliant, germination inhibiting and especially weed-killing activities
10/26/2000CA2370389A1 Novel synthesis of piperazine ring
10/26/2000CA2370231A1 Haloalkoxy imidazonaphthyridines
10/26/2000CA2368815A1 Novel synthesis and crystallization of piperazine ring-containing compounds
10/25/2000EP1045850A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
10/25/2000EP1045849A1 Purine derivatives having phosphodiesterase iv inhibition activity
10/25/2000EP1045843A1 Inhibitors of farnesyl-protein transferase
10/25/2000EP0720601B1 Gastrin and cck receptor ligands
10/25/2000CN1271348A Method for producing (hetero) aromatic hydroxylamines
10/25/2000CN1270960A Process for preparing growth hormone cinogenic agent
10/25/2000CN1057772C Compounds and compositions for treatment of immunomediated inflammatory disorders
10/24/2000US6136978 Camptothecin analogs and methods of preparation thereof
10/24/2000US6136861 Bicyclo[2.2.1]heptanes and related compounds
10/24/2000US6136823 Pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient
10/24/2000US6136821 Naphthyridine derivatives
10/24/2000US6136810 Pyrido[2,3-D]pyrimidine derivatives and pharmaceutical compositions thereof
10/19/2000WO2000061581A1 Amine derivatives
10/19/2000WO2000061556A1 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
10/19/2000WO2000061541A2 Pharmaceutical compounds
10/19/2000WO2000061146A1 Camptothecin analogs and methods of preparation thereof
10/19/2000WO2000007996A8 Pyrazoles as estrogen receptor modulators
10/19/2000CA2370425A1 Pharmaceutical compounds
10/19/2000CA2369971A1 Aryl or heteroaryl fused imidazole derivatives, their pharmaceutical compositions and agents, and uses thereof
10/19/2000CA2369103A1 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
10/18/2000EP1044975A1 Stable crystalline salts of 5-methyltetrahydrofolic acid
10/18/2000EP1044969A2 Processes and intermediates for preparing anti-cancer compounds
10/18/2000EP1044201A1 3-substituted adenines via2-thioxanthines
10/18/2000EP1044197A2 New piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/18/2000EP1044189A1 Aryl fused azapolycyclic compounds
10/18/2000EP1044001A1 Integrin receptor antagonists
10/18/2000EP1043999A1 Novel substituted pyridine compounds useful as modulators of acetylcholine receptors
10/18/2000EP1043998A1 USE OF PYRAZOLO 3,4-b] PYRIDINE AS CYCLIN DEPENDENT KINASE INHIBITORS
10/18/2000EP1043997A1 A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound
10/18/2000EP1043991A1 Treatment for alzheimer's disease
10/18/2000EP1043976A1 Oral pharmaceutical extended release dosage form
10/18/2000EP0633886B1 Pharmaceutically active bicyclic-heterocyclic amines
10/18/2000EP0603251B1 1-substituted 1h-imidazo(4,5-c)quinolin-4-amines; intermediate and pharmaceutical compositions
10/18/2000CN1270593A Pyrimidin-4-one and pyrimidin-4-thione as fungicide
10/17/2000US6133445 Rigidized trimethine cyanine dyes
10/17/2000US6133290 Derivatives of 3-piperidin-4-yl-1h-indazolines; inhibit peptide extravasation due to stimulation of the trigeminal ganglia; treatment of migraines and associated disorders
10/17/2000US6133284 Excellent bactericidal properties and oral absorption; infections from gramnegative and -positive bacteria; intestinal absorption, metabolic stability; side effect reduction; nonphototoxicity and noncytotoxicity
10/17/2000US6133282 Agonists or antagonists at human corticotropin-releasing factor 1 (crf1) receptors; useful in diagnosis and treatment of treating stress related disorders, e.g., post trumatic stress disorder and headache; antidepressants; anxiolytic
10/17/2000US6133276 A ligand inhibitor of a crf/crf-binding protein complex to effect increased levels of crf; 2,4-dioxo- or 2-thiocarbonyl-4-oxo-5-(hydrocarbyl(thio)carbonylaminomethyl)-6-hydroxy-hexa-hexahydropyrimidines; alzheimer's, obesity; low side effects
10/17/2000US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
10/17/2000US6133255 Useful in the therapy of deleterious mental states; psychological disorders
10/17/2000CA2001205C Antimicrobial quinolonyl lactams
10/12/2000WO2000059905A1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS
10/12/2000WO2000059904A2 Compounds and methods to treat cardiac failure and other disorders
10/12/2000WO2000059889A1 α-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES
10/12/2000WO2000059887A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives and their use as antidiabetics
10/12/2000WO2000059886A2 Benzimidazole abd imidazolophyridine derivaties, their preparation and their use as selective modulators of bradykinin b2 (=bk-2) receptors
10/12/2000WO2000059884A1 Pharmaceutically active compounds and methods of use thereof
10/12/2000WO2000059510A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors
10/12/2000WO2000059503A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059502A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO1999064039A9 Bradykinin antagonists
10/12/2000CA2373717A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2369871A1 .alpha.-substituted carboxylic acid derivatives
10/12/2000CA2369557A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of gabaa receptors
10/12/2000CA2369549A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives and their use as antidiabetics
10/12/2000CA2369544A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives:selective modulators of bradykinin b2 receptors
10/12/2000CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000CA2366944A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2366858A1 Sorbitol dehydrogenase inhibitors
10/12/2000CA2361734A1 Pharmaceutically active compounds and methods of use thereof
10/11/2000EP1043326A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043325A1 Steroid receptor modulator compounds and methods
1 ... 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 ... 646